Sort
25,944 grants matching “neurodegeneration”
Phosphorylation-mediated inhibition of MEF2 in neuron
$232,500Zixu Mao · Emory University · R01 · FY2009 · AG
Hyaluronan and the microvascular and neuropathology of Alzheimerâs Disease
$232,500May J Reed · University Of Washington · R21 · FY2017 · AG
Role of RTEL1 in Microhomology-Mediated End Joining
$232,500Sang Eun Lee · University Of Texas Hlth Science Center · R21 · FY2022 · ES
Hematopoietic stem cell-based therapy for Friedrich Ataxia
$232,500Stephanie Cherqui · University Of California, San Diego · R21 · FY2015 · NS
Novel Molecular Genetic Approaches for the Prevention and Treatment of Parkinsons
$232,500Thomas Hnasko · University Of California, San Diego · R21 · FY2015 · NS
Effect of pathogenic tau on entorhinal cortical inputs to dentate gyrus interneurons
$232,500Adam Rory McQuiston · Virginia Commonwealth University · R21 · FY2017 · AG
The effects of amyloid beta on pericyte remodeling and brain capillary function in vivo
$232,500Andy Y Shih · Seattle Children'S Hospital · R21 · FY2020 · AG
Molecular profiling of familial and sporadic Alzheimer's disease
$232,500Scott Edward Counts · Michigan State University · R21 · FY2016 · AG
Spinal Muscular Atrophy: Cell-based drug screens for treatment of axonal defects
$232,500Wilfried Rossoll · Emory University · R21 · FY2010 · NS
Dieldrin exposure and synucleinopathy
$232,500Alison Bernstein · Michigan State University · R21 · FY2018 · ES
Conserved Mechanisms of Aging in Alzheimer Disease
$232,500Daniel Edward Lee Promislow · University Of Washington · R21 · FY2017 · AG
Pathologically modified TDP-43 in neurodegenerative diseases
$232,500Tania France Gendron · Mayo Clinic Jacksonville · R21 · FY2011 · NS
Alpha-synuclein is crucial for neuronal function and survival-Characterization of a novel conditional alpha-synuclein knockout mouse model
$232,500Fredric Manfredsson · Michigan State University · R21 · FY2016 · NS
Aminopeptidases for Neurotoxic Pyroglutamate Beta-Amyloid of Alzheimers Disease
$232,500Vivian Y. H. Hook · University Of California, San Diego · R21 · FY2013 · AG
Imaging Core
$232,448Richard B. Lipton · Albert Einstein College Of Medicine · P01 · FY2012 · AG
PET and MRI Evaluation of Cerebral Inflammation and Metabolic Stress in Relapsing Multiple Sclerosis
$232,410Matthew Ryan Brier · Washington University · K23 · FY2025 · NS
Understanding the Mechanisms of TDP-43 Function
$232,403Yongjie Zhang · Mayo Clinic Jacksonville · R21 · FY2014 · NS
Adenosine, Glutamate and Neurodegeneration
$232,389Patricia K Sonsalla · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2007 · NS
Activators of Nrf2/ARE pathway as therapeutic target for Parkinson's Disease
$232,375Bobby Thomas · Weill Medical Coll Of Cornell Univ · R21 · FY2010 · NS
The role of Nemo-like kinase in neurodegeneration
$232,359Janghoo Lim · Yale University · R00 · FY2012 · NS
Molecular mechanisms of C9orf72 and Matrin 3 interaction in ALS
$232,313Udai B Pandey · University Of Pittsburgh At Pittsburgh · R21 · FY2017 · NS
Activators of Nrf2/ARE pathway as therapeutic target for Parkinson's Disease
$232,260Bobby Thomas · Weill Medical Coll Of Cornell Univ · R21 · FY2009 · NS
PROTEOGLYCANS, SYNAPTIC PLASTICITY IN AGING AND DISEASE
$232,219Paul E Gottschall · Univ Of Arkansas For Med Scis · R01 · FY2010 · AG
Reverse electron transport and tauopathy
$232,144Bingwei Lu · Stanford University · R21 · FY2024 · AG
NEUROBIOLOGY
$232,128Eliezer Masliah · University Of California, San Diego · P01 · FY2006 · DA